Ginkgo Bioworks (DNA) Projected to Post Quarterly Earnings on Tuesday

Ginkgo Bioworks (NYSE:DNA) is expected to post its quarterly earnings results after the market closes on Tuesday, February 25th. Analysts expect Ginkgo Bioworks to post earnings of ($1.45) per share and revenue of $44.43 million for the quarter. Individual that are interested in participating in the company’s earnings conference call can do so using this link.

Ginkgo Bioworks Trading Down 5.0 %

DNA opened at $10.86 on Monday. Ginkgo Bioworks has a one year low of $5.26 and a one year high of $64.40. The stock has a market cap of $623.95 million, a P/E ratio of -0.83 and a beta of 1.16. The firm has a 50-day simple moving average of $11.48.

Ginkgo Bioworks Company Profile

Ginkgo Bioworks Holdings, Inc, together with its subsidiaries, develops platform for cell programming in the United States. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. It serves pharma and biotech, agriculture, industrial and environment, food and nutrition, consumer and technology, and government and defense industries.